Table 2.
Clinical response after completion of radiotherapy.
| CCRT alone (n=58) | CCRT+ICI (n=43) | P | |
|---|---|---|---|
| Complete response | 0.037 | ||
| no | 57 (98.3%) | 38 (88.4%) | |
| yes | 1 (1.7%) | 5 (11.6%) | |
| Partial response | 0.766 | ||
| no | 32 (55.2%) | 25 (58.1%) | |
| yes | 26 (44.8%) | 18 (41.9%) | |
| Stable disease | 0.097 | ||
| no | 31 (53.4%) | 30 (69.8%) | |
| yes | 27 (46.6%) | 13 (30.2%) | |
| Progressive disease | 0.999 | ||
| no | 58 (100.0%) | 43 (100.0%) | |
| yes | 0 (0.0%) | 0 (0.0%) | |
| Unknown | 0.134 | ||
| no | 54 (93.1%) | 36 (83.7%) | |
| yes | 4 (6.9%) | 7 (16.3%) | |
| Objective response rate | 0.491 | ||
| no | 31 (53.4%) | 20 (46.5%) | |
| yes | 27 (46.6%) | 23 (53.5%) | |
| Disease control rate | 0.134 | ||
| no | 4 (6.9%) | 7 (16.3%) | |
| yes | 54 (93.1%) | 36 (83.7%) |
CCRT, concurrent chemoradiotherapy; ICI, immune checkpoint inhibitors.